Studies

  1. Ritlecitinib and Brepocitinib in UC

  2. Ustekinumab vs Infliximab in CD

  3. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

  4. Ferric carboxymaltose vs Ferrous fumarate in Anemic children with IBD

  5. Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in IBD Patients

  6. Tofacitinib vs oral prednisolone in moderately active UC

  7. Olamkicept induction in ulcerative colitis

  8. Mediterranean Diet vs Canadian diet in quiescent UC

  9. Mercaptopurine in UC for maintenance

  10. Mirikizumab induction and maintenance